EN
CN
EN
About Us
About Viva Biotech
Corporate Culture
History&Awards
Management Team
Environmental, Social and Governance (ESG)
Business Conduct and Ethics
CRO Services
Service & Technology
New Modalities
Protein Expression and Purification
Membrane Protein Targeted Discovery Technology
Structural Biology Services
X-ray Crystal Structure Analysis of Protein
Cryo-EM Technology Platform
Hit Discovery
V-DEL
ASMS
SPR
Virtual Screening
Crystal Soaking
Intact-MS
HTS
Bioassay
Biomolecular Interaction
ASMS
SPR
HDX-MS
Native-MS
Intact-MS
TSA
X-ray Crystal Structure Analysis of Protein
Cryo-EM Technology Platform
Microcrystal Electron Diffraction(MicroED)
AIDD/CADD
Chemistry Services
Medicinal Chemistry
Synthetic Chemistry
Analytical Chemistry
Purification Preparation
Chemical Technology Platforms
Pharmacology
Product Center
Product Catalogue
Drug Discovery Product
Antibody/Biologics R&D Services
Antibody Discovery
Antibody Engineering
Bispecific Antibody Platform
Assay Platform
Antibody Production and Identification Platform
Epitope Mapping Platform
PROTAC/Molecular Glue Services
Protein Preparation and Ternary Complex Structure Determination
PROTAC/Molecular Glues Screening
PROTAC Ternary Complex Kinetics (SPR)
PROTAC Degradation Assays and Ternary Complex Assays
PROTAC Molecule Design and Synthesis
ADME & PK/PD Studies of PROTAC Molecules
AIDD/CADD PROTAC Design
XDC Platform
XDC Conjugation and Quality Study
XDC Chemistry R&D
XDC Functional Studies
Peptide Drug Discovery Services
Peptide Screening Platform
AIDD/CADD Empowered
Peptides Optimization
Peptide Synthesis
Bioassay Platform
Antibody-Peptide Conjugates
CDMO Services
EFS Business
News
Company News
Events
Portfolio Highlights
Video Center
Careers
Working at VIVA
Total Rewards
Cutting-edge Laboratory
Investor Relations
Corporate Governance
Information Disclosure
Presentations & Webcasts
IR Newsletter
Investors Contact
Contact Us
News
Company News
Events
Portfolio Highlights
Video Center
Portfolio Highlights
Year
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Month
01
02
03
04
05
06
07
08
09
10
11
12
2023-07-07
Latest Updates of 5 Viva's Portfolio Companies
2023-06-09
DTx Pharma Receives FDA Orphan Drug Designation for DTx-1252 for the Treatment of Charcot-Marie-Tooth Disease Type 1A (CMT1A)
2023-06-05
VVN539, a dual-target innovative drug for glaucoma independently developed by VivaVision, reached the primary research endpoint in the Phase II clinical trial in the United States
2023-06-05
Domain Therapeutics announces nomination of first-in-class PAR2 NAM candidate, DT-9045, to unlock new cancer treatment possibilities
2023-06-02
Latest Updates of 7 Viva's Portfolio Companies
2023-05-06
VivaVision Announced the Completion of Over 100 million RMB in Series D2 Financing
2023-05-05
ABM Announces First Patient Dosed in Phase I Clinical Trial of MEK Inhibitor for Solid Tumor
2023-04-25
Latest Updates of 3 Viva's Portfolio Companies
2023-04-19
Technoderma Medicines Initiates TDM-105795 Androgenetic Alopecia Phase 2 Clinical Trial
2023-04-04
Latest Updates of 6 Viva's Portfolio Companies
2023-03-16
Mediar Therapeutics Announces $105 Million Financing to Advance Portfolio of First-in-Class Fibrosis Therapies
2023-03-14
AmacaThera Doses First Subjects in Phase 1 Clinical Trial for AmacaGel™ Therapeutic Platform
<
1
2
3
4
5
6
7
8
9
10
>
Media contact:
vivapr@vivabiotech.com
Contact Us
About Us
Back
About Us
About Viva Biotech
Corporate Culture
History&Awards
Management Team
Environmental, Social and Governance (ESG)
Business Conduct and Ethics
CRO Services
Back
CRO Services
Service & Technology
Back
Service & Technology
Protein Expression and Purification
Back
Protein Expression and Purification
Membrane Protein Targeted Discovery Technology
Structural Biology Services
Back
Structural Biology Services
X-ray Crystal Structure Analysis of Protein
Cryo-EM Technology Platform
Hit Discovery
Back
Hit Discovery
V-DEL
ASMS
SPR
Virtual Screening
Crystal Soaking
Intact-MS
HTS
Bioassay
Biomolecular Interaction
Back
Biomolecular Interaction
ASMS
SPR
HDX-MS
Native-MS
Intact-MS
TSA
X-ray Crystal Structure Analysis of Protein
Cryo-EM Technology Platform
Microcrystal Electron Diffraction(MicroED)
AIDD/CADD
Chemistry Services
Back
Chemistry Services
Medicinal Chemistry
Synthetic Chemistry
Analytical Chemistry
Purification Preparation
Chemical Technology Platforms
Pharmacology
Product Center
Back
Product Center
Product Catalogue
Drug Discovery Product
New Modalities
Back
New Modalities
Antibody/Biologics R&D Services
Back
Antibody/Biologics R&D Services
Antibody Discovery
Antibody Engineering
Bispecific Antibody Platform
Assay Platform
Antibody Production and Identification Platform
Epitope Mapping Platform
PROTAC/Molecular Glue Services
Back
PROTAC/Molecular Glue Services
Protein Preparation and Ternary Complex Structure Determination
PROTAC/Molecular Glues Screening
PROTAC Ternary Complex Kinetics (SPR)
PROTAC Degradation Assays and Ternary Complex Assays
PROTAC Molecule Design and Synthesis
ADME & PK/PD Studies of PROTAC Molecules
AIDD/CADD PROTAC Design
XDC Platform
Back
XDC Platform
XDC Conjugation and Quality Study
XDC Chemistry R&D
XDC Functional Studies
Peptide Drug Discovery Services
Back
Peptide Drug Discovery Services
Peptide Screening Platform
AIDD/CADD Empowered
Peptides Optimization
Peptide Synthesis
Bioassay Platform
Antibody-Peptide Conjugates
CDMO Services
EFS Business
News
Back
News
Company News
Events
Portfolio Highlights
Video Center
Careers
Back
Careers
Working at VIVA
Total Rewards
Cutting-edge Laboratory
Investor Relations
Back
Investor Relations
Corporate Governance
Information Disclosure
Presentations & Webcasts
IR Newsletter
Investors Contact
Contact Us